Panbela announces transfer to otcqb market

Minneapolis, april 16, 2024 (globe newswire) -- panbela therapeutics, inc. (otcqb: pbla), (“panbela”), a clinical stage company developing disruptive therapeutics for the treatment of patients with urgent unmet medical needs, today announced that its common stock has been approved for quotation on the otcqb market. panbela's common stock will be eligible for quotation on the otcqb starting on april 17, 2024, under the symbol “pbla.”
PBLA Ratings Summary
PBLA Quant Ranking